Objective: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow obstruction. As the disease progresses, it affects several organs and systems. So, the aim of this study was to evaluate the efficacy of diffusion-weighted imaging (DWI) of the brain in defining deep white matter integrity in COPD patients, and correlate apparent diffusion coefficient (ADC) values to COPD stage, pulmonary function tests and arterial blood gases. Methods: A cross-sectional case-control study included 20 COPD male patients (smokers), aged 51-78 years and 18 healthy male volunteers, non-smokers with matched age (45-71 years), represented the control group. All the subjects were neurologically free (on examination) with no known history of cerebrovascular disease, renal impairment, chronic hepatic disease or any other disease which may have a cerebral effect. Spirometry, arterial blood gases and COPD staging were done for COPD patients. DWI was done for both groups. Results: Both groups were age matched (P 0.231). All apparent diffusion coefficient (ADC) values were higher in COPD patients than the healthy (control) group. ADC values taken from the frontal, temporal and parietal deep white matter of COPD patients had statistically significant difference compared to those of the control group (P values = 0.016 & 0.013 and 0.002 respectively). No significant correlation between ADC values measured from all lobes and arterial blood gases, FEV1 or COPD staging. Conclusion: ADC values are increased significantly in COPD patients than in normal populations denoting affected integrity of white matter, however this increase is not related to COPD severity, arterial hypoxemia, hypercapnia or other disease markers like FEV1.
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow obstruction. As the disease progresses, it affects several organs and systems [1, 2] . The systemic effects of COPD are caused by oxidative stress and altered circulating levels of inflammatory mediators and acute-phase proteins [1] . COPD can cause changes in the cerebral blood flow as well as all vascular structures [3] . Chronic hypoperfusion is considered to play a significant role in the development of white matter lesions [4] . In addition, the systemic inflammation may lead to neuronal damage in the brain of patients with COPD [5] .
Diffusion-weighted imaging (DWI) has become a basic technique of modern clinical imaging, mainly to investigate the diseased brain. Diffusing water molecules provide unique information on the white matter microstructure and integrity [6] . DWI is a noninvasive magnetic resonance imaging technique that is commonly used today. It defines the tissues in relation to the diffusion properties of their water content, particularly with high b values. DWI can be used to measure quantitatively the increased free water content in the cerebral tissue caused by damage to http the myelin and axons [7, 8] . Increased apparent diffusion coefficient (ADC) values can result from chronic pathological conditions like chronic hypoxia-ischemia, gliosis and demyelination [8] .
The aim of the work
The aim of this study was to evaluate the efficacy of DWI in defining deep white matter integrity in the patients with COPD, and correlate apparent diffusion coefficient (ADC) values to COPD severity staging, pulmonary function tests and arterial blood gases abnormalities.
Patients and methods

Patients
A cross-sectional case-control study included twenty COPD male patients (smokers), aged 51-78 years from February 2015 to September 2015, presented at Mansoura University Hospital. Eighty healthy male volunteers, non-smokers with matched age (45-71 years), represented the control group. All the subjects were free from a known history of cerebrovascular disease, renal impairment, chronic hepatic disease or any other disease which may have a cerebral effect.
COPD diagnosis and staging
The diagnosis and staging of COPD patients was done according to GOLD guidelines [ 
Pulmonary function tests
Spirometry (BTL-08 spiro, Germany) was performed to determine the lung function measurements and bronchodilator reversibility. Post bronchodilator FEV1/FVC% and FEV1 were measured 15 min after inhalation of 400 lg of salbutamol. Arterial blood gases were done for COPD cases for assessment of hypoxemia, hypercapnia or PH changes.
-All patients were assessed neurologically with no evident abnormal findings. -No sedative agents were used prior to magnetic resonance imaging and no contrast administration during the imaging. A consent was taken from COPD patients and healthy control group.
Image acquisition
All examinations were performed on a 1.5 T MRI scanner Philips Ingenie (Philips health care, Heide, Netherland). A clinical MR imaging brain protocol that included sagittal spin-echo T1-weighted images, axial T2-weighted, axial fluid-attenuated inversion recovery sequence (FLAIR) and coronal images were acquired. Diffusion weighted spin-echo single-shot echo planar pulse sequence used to generate ADC values and acquired by selecting repetition time 4600 ms-echo time 110 ms-FOV 212 mm-matrix 212 Â 212-NEX 3. Images were obtained with values of b 0, 500, 1000 mm 2 /sec. ADC maps of the images were automatically generated and the ADC values were measured on this map for all patients.
Image analysis
Conventional MRI analysis: FLAIR and T2-weighted images were used to assess brain atrophy, vascular white matter hyperintensities and lacunar infarctions.
White matter integrity: A circular region of interest (ROI) was placed within the cerebral white matter of the frontal, temporal, parietal and occipital regions on both sides, with exclusion of partial-voluming with CSF and grey matter. Quantitative measurements of ADC values with a commercially available software package were derived. For each patient, three measurements were taken. The mean of the obtained three ADC values was used for evaluation.
Statistical analysis
Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 20 for Windows. Data were obtained as mean, standard deviations, minimum and maximum values for both the COPD and control group. Independent sample t-test as used for the comparison of means between the two groups. Statistical significance was accepted at the level of P < 0.05. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic performance of DWI in defining white matter integrity in COPD patients. Sensitivity, specificity and area under the curve (AUC) calculations were made for the ADC values. Threshold values were compared between COPD patients and control groups.
Results
This study included 20 male COPD patients with mean age and standard deviation were 62.10 ± 7.44 years (range 51-78 years), and that of the 18 healthy individuals was 58.22 ± 8.87 years (range 45-71 years). Statistically significant difference was not detected between the groups for age distribution (P 0.231).
Reviewing the conventional MR images using Fazekas visual rating scale showed relative increased number and burden of white matter lesions in COPD patients (40%) compared to (healthy) control group (16.6%), but with no significant difference (p = 0.113). No significant increase in brain atrophy in patients with COPD compared to (healthy) control group (p = 0.723) as shown in Table 1 .
The measurement of ADC values from the frontal, temporal, parietal and occipital white matter areas of COPD patients and Frontal 0.83 ± 0.06 Â 10 À3 mm 2 /sec 0.77 ± 0.04 Â 10 À3 mm 2 /sec 0.016 ⁄ Temporal 0.85 ± 0.02 Â 10 À3 mm 2 /sec 0.82 ± 0.03 Â 10 À3 mm 2 /sec 0.013 ⁄ Parietal 0.78 ± 0.06 Â 10 À3 mm 2 /sec 0.80 ± 0.06 Â 10 À3 mm 2 /sec 0.002 ⁄ Occipital 0.81 ± 0.09 Â 10 À3 mm 2 /sec 0.78 ± 0.06 Â 10 À3 mm 2 /sec 0.727 
-Specificity
Discussion
Chronic obstructive pulmonary disease (COPD) continues to be a major cause of morbidity and mortality. It is increasingly recognised that COPD extends beyond the lung to the brain [5] .
Diffusion-weighted magnetic resonance imaging provides potentially unique information on the viability of brain tissue. It provides image contrast that is dependent on the molecular motion of water, which may be substantially altered by disease [10] . Currently, diffusion-weighted imaging is the most reliable method for detection of early and small ischemic infarcts in the brain. However, applications of this imaging technique extend far beyond the work-up of acute ischemia and are increasingly used for the evaluation of a large variety of neoplastic and non neoplastic conditions affecting the brain (Tables 4 and 5 ).
In this study standard MRI techniques were used for assessment of white matter lesions and global brain atrophy, while ADC was used to assess the white matter integrity quantitatively. We based our results of white matter hyperintensities on Fazekas scale which is one of the best visual scales in assessment of age related white matter changes. This is a four-grade rating scale, absence of lesions matches to grade 0; presence of non-confluent focal lesions matches to grade 1; initially confluent lesions matches to grade 2; diffuse confluent lesions matches to grade 3 [11] .
Our present study revealed that patients with COPD had no significant increase in associated brain atrophy. Such finding coincides with that obtained by Dodd and colleagues [12] who reported that the patients with COPD did not have generalized cerebral atrophy.
Our results showed that there is increased number and burden of white matter lesions in patients with COPD compared with healthy control group, which is matching also with the results of Dodd and colleagues [12] , who found that white matter lesions were significantly higher in COPD patients than in control subjects.
ADC is a quantitative measurement of the random microscopic motion of water molecules in different tissues. ADC values are increased with the increase of free water content in the white matter as a result of damage of myelin and axons [13] . The findings of the present study demonstrated that ADC values measured in normally appearing white matter of frontal, parietal and temporal lobes on both sides are significantly higher in COPD patients than in those of healthy (control) group. Also there is high sensitivity and specificity in defining frontal, temporal and parietal white matter changes. However there is reduced specificity in detecting white matter changes in occipital lobes. These findings support the findings obtained by Cullu et al. [14] who found that ADC values in the deep white matter of all brain lobes of patients with COPD to be significantly higher than the control group.
In this study, ADC values in COPD patients were not correlated to arterial hypoxemia, hypercapnia or FEV1. These findings were similar to Dodd and colleagues [12] who provided evidence of significant white and gray matter abnormalities associated with cognitive dysfunction in patients with COPD without arterial hypoxemia or hypercapnia.
James et al. [15] , have shown also that in stable non hypoxemic patients with COPD there was evidence of white matter microstructural damage throughout the brain In COPD patients James et al. [15] , tested to see whether COPD factors, such as FEV1 and arterial saturation were related to the degree of white matter damage, but no associations were found. So, they hypothesized, but cannot prove, that the most likely mechanism is microvascular damage.
In contrast, van Dijk et al. [16] found that COPD and lower arterial oxygen saturation (SaO2) are associated with severe periventricular white matter lesions. They suggested that both cerebral hypoperfusion and hypoxemia may be leading causes of periventricular white matter lesions.
The absence of an association between brain damage and other pulmonary-specific disease markers is not unexpected because other complex extrapulmonary manifestations of COPD may not be strongly related to pulmonary markers [17] . For example unexplained weight loss has been associated with poor prognosis, independent of FEV 1 and Pa o2 [18] . Till now, the mechanisms responsible for white matter damage are not fully established.
These findings emphasize the importance of organ dysfunction outside the lung in the morbidity and mortality associated with the development of COPD and strengthen the need for a broad approach to the care of these patients [19] . Further studies are required to dissect the mechanisms by which smoking, COPD, or both contribute to white matter abnormalities in patients with COPD so that targeted interventions can be initiated early in the disease.
Conclusion
ADC values are increased significantly in COPD patients than in normal populations denoting affected integrity of white matter, however this increase is not related to COPD severity, arterial hypoxemia, hypercapnia or other disease markers like FEV1. Chronic hypoperfusion, systemic inflammatory mediators and cerebral microcirculation defect were considered to play significant role in the development of white matter lesions. But the exact mechanisms responsible for white matter damage are not fully established.
Recommendations
Further studies (on larger number of patients with different clinical, laboratory and radiological evaluation) are needed to discover the extra-pulmonary cerebral manifestations of COPD and the mechanisms by which smoking, COPD, or both contribute to white matter and other cerebral abnormalities in patients with COPD. So that targeted interventions can be initiated early in the disease Table 4 Correlation between ADC values measured from the frontal, temporal, parietal, occipital deep white matter of COPD patients and arterial blood gases (pao2, paco2 and ph), FEV1. No significant correlation between ADC values measured from these lobes and arterial blood gases or FEV1. 
